| Affinis Hospice, Llc 806 Maple Drive, Vidalia, GA, 30474 | |
| (912) 538-0465 |
News Archive
Researchers in the United States have identified cardiopulmonary processes that may partly explain why some individuals with coronavirus disease 2019 (COVID-19) develop respiratory failure.
It could take a mere 30 seconds to spot signs of Alzheimer's disease in 40 year-olds in the near future say scientists who are developing a new diagnostic test. Usually Alzheimer's disease is detected much later in life after the symptoms begin to appear.
The NHS is developing new ways to help older people maintain and improve their health and avoid hospital admission under a new healthcare programme being piloted in nine English primary care trusts. Interim results of the pilot sites have been welcomed today by the Department of Health.
New potential biomarkers and a novel algorithm could help identify patients at increased risk of suffering from severe neurotoxicity after receiving CD19 CAR T-cell therapy. The study extensively characterized common and occasionally fatal side effects of this immunotherapy.
These results reveal how the immune system can then limit the effectiveness of some cancer chemotherapies. The researchers now intend to block the molecules responsible for negative immune system activation to increase the efficiency of chemotherapy. A clinical trial to test this hypothesis should begin very soon.
› Verified 5 days ago
| Name | Affinis Hospice, Llc |
|---|---|
| Location | 806 Maple Drive, Vidalia, Georgia |
| Hospice ID | 111746 |
| Category | Freestanding Hospice |
| Ownership Type | Voluntary Non-profit - Private |
| Profit Type | NON-PROFIT |
| SSA county code | 901 |
News Archive
Researchers in the United States have identified cardiopulmonary processes that may partly explain why some individuals with coronavirus disease 2019 (COVID-19) develop respiratory failure.
It could take a mere 30 seconds to spot signs of Alzheimer's disease in 40 year-olds in the near future say scientists who are developing a new diagnostic test. Usually Alzheimer's disease is detected much later in life after the symptoms begin to appear.
The NHS is developing new ways to help older people maintain and improve their health and avoid hospital admission under a new healthcare programme being piloted in nine English primary care trusts. Interim results of the pilot sites have been welcomed today by the Department of Health.
New potential biomarkers and a novel algorithm could help identify patients at increased risk of suffering from severe neurotoxicity after receiving CD19 CAR T-cell therapy. The study extensively characterized common and occasionally fatal side effects of this immunotherapy.
These results reveal how the immune system can then limit the effectiveness of some cancer chemotherapies. The researchers now intend to block the molecules responsible for negative immune system activation to increase the efficiency of chemotherapy. A clinical trial to test this hypothesis should begin very soon.
› Verified 5 days ago
| NPI Number | 1780011528 |
| Organization Name | Affinis Hospice, Llc |
| Address | 806 Maple Dr Vidalia, Georgia, 30474 |
| Phone Number | (912)538-0465 |
News Archive
Researchers in the United States have identified cardiopulmonary processes that may partly explain why some individuals with coronavirus disease 2019 (COVID-19) develop respiratory failure.
It could take a mere 30 seconds to spot signs of Alzheimer's disease in 40 year-olds in the near future say scientists who are developing a new diagnostic test. Usually Alzheimer's disease is detected much later in life after the symptoms begin to appear.
The NHS is developing new ways to help older people maintain and improve their health and avoid hospital admission under a new healthcare programme being piloted in nine English primary care trusts. Interim results of the pilot sites have been welcomed today by the Department of Health.
New potential biomarkers and a novel algorithm could help identify patients at increased risk of suffering from severe neurotoxicity after receiving CD19 CAR T-cell therapy. The study extensively characterized common and occasionally fatal side effects of this immunotherapy.
These results reveal how the immune system can then limit the effectiveness of some cancer chemotherapies. The researchers now intend to block the molecules responsible for negative immune system activation to increase the efficiency of chemotherapy. A clinical trial to test this hypothesis should begin very soon.
› Verified 5 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 97.8 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 91.1 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 96.7 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 87.2 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 98.9 | 97.3 |
| Patients who got timely treatment for shortness of breath | 55.2 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 89.3 | 93.3 |
News Archive
Researchers in the United States have identified cardiopulmonary processes that may partly explain why some individuals with coronavirus disease 2019 (COVID-19) develop respiratory failure.
It could take a mere 30 seconds to spot signs of Alzheimer's disease in 40 year-olds in the near future say scientists who are developing a new diagnostic test. Usually Alzheimer's disease is detected much later in life after the symptoms begin to appear.
The NHS is developing new ways to help older people maintain and improve their health and avoid hospital admission under a new healthcare programme being piloted in nine English primary care trusts. Interim results of the pilot sites have been welcomed today by the Department of Health.
New potential biomarkers and a novel algorithm could help identify patients at increased risk of suffering from severe neurotoxicity after receiving CD19 CAR T-cell therapy. The study extensively characterized common and occasionally fatal side effects of this immunotherapy.
These results reveal how the immune system can then limit the effectiveness of some cancer chemotherapies. The researchers now intend to block the molecules responsible for negative immune system activation to increase the efficiency of chemotherapy. A clinical trial to test this hypothesis should begin very soon.
› Verified 5 days ago
| Home Health Aides | 4 |
| Counselors | 1 |
| Medical Social Workers | 1 |
| Physicians | 2 |
| Registered Nurses | 3 |
| Other Personnel | 1 |
| Total Employees | 12 |
|---|
News Archive
Researchers in the United States have identified cardiopulmonary processes that may partly explain why some individuals with coronavirus disease 2019 (COVID-19) develop respiratory failure.
It could take a mere 30 seconds to spot signs of Alzheimer's disease in 40 year-olds in the near future say scientists who are developing a new diagnostic test. Usually Alzheimer's disease is detected much later in life after the symptoms begin to appear.
The NHS is developing new ways to help older people maintain and improve their health and avoid hospital admission under a new healthcare programme being piloted in nine English primary care trusts. Interim results of the pilot sites have been welcomed today by the Department of Health.
New potential biomarkers and a novel algorithm could help identify patients at increased risk of suffering from severe neurotoxicity after receiving CD19 CAR T-cell therapy. The study extensively characterized common and occasionally fatal side effects of this immunotherapy.
These results reveal how the immune system can then limit the effectiveness of some cancer chemotherapies. The researchers now intend to block the molecules responsible for negative immune system activation to increase the efficiency of chemotherapy. A clinical trial to test this hypothesis should begin very soon.
› Verified 5 days ago
| Others | 2 |
| Total Volunteers | 2 |
|---|
News Archive
Researchers in the United States have identified cardiopulmonary processes that may partly explain why some individuals with coronavirus disease 2019 (COVID-19) develop respiratory failure.
It could take a mere 30 seconds to spot signs of Alzheimer's disease in 40 year-olds in the near future say scientists who are developing a new diagnostic test. Usually Alzheimer's disease is detected much later in life after the symptoms begin to appear.
The NHS is developing new ways to help older people maintain and improve their health and avoid hospital admission under a new healthcare programme being piloted in nine English primary care trusts. Interim results of the pilot sites have been welcomed today by the Department of Health.
New potential biomarkers and a novel algorithm could help identify patients at increased risk of suffering from severe neurotoxicity after receiving CD19 CAR T-cell therapy. The study extensively characterized common and occasionally fatal side effects of this immunotherapy.
These results reveal how the immune system can then limit the effectiveness of some cancer chemotherapies. The researchers now intend to block the molecules responsible for negative immune system activation to increase the efficiency of chemotherapy. A clinical trial to test this hypothesis should begin very soon.
› Verified 5 days ago
| Community Hospice Location: 904 Mount Vernon Road, Vidalia, Georgia, 30474 Phone: (912) 538-0465 |
| Affinis Hospice, Llc Location: 806 Maple Drive, Vidalia, Georgia, 30474 Phone: (912) 538-0465 |